It helps reduce stress and enhances cognitive function, making it beneficial for both physical and mental well-being
Treatment with exenatide has been shown to decrease food intake and attenuate food-related neural responses in key regions such as the insula, amygdala, putamen, and orbitofrontal cortex (van Bloemendaal et al., 2014)
GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List Less than a week after the U.S
The study included a survey with 1,955 useable observations including 495 people who were currently taking a GLP-1, 468 who had previously taken one, 492 people who were planning to take one, and 500 people who were neither taking one nor planning to take one
Although designed for non-inferiority, the SUSTAIN-6 (NCT01720446) trial showed a 2.3% reduction in MACEs in patients with T2D in patients taking weekly injectable semaglutide